Snowball logo
logo
NWRN

Newron Pharmaceuticals SpA

Fr12.94+Fr1.22Β  (10.41%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
5.7626.0949.05751.3919.1373.49
COGS
0.1170.4430.4710.8922.1053.045811
Gross Profit
5.7626.0949.05751.3919.1373.48
Operating Expenses & Income
Operating Income
(12.36)(13.3)(11.63)26.17(4.697)23.19
Total Operating Expenses
18.1219.420.6925.2223.8150.21
R&D Expenses
10.7612.0513.1513.6415.1629.52
Selling General & Admin Expenses
3.4933.5363.9827.3794.76512.48
Earnings from Continuing Operations
Interest Expense
(2.918)(4.363296)(4.168)(4.353)(4.431763)(8.71622)
Interest Income
2.6610.0560.1790.1380.5398.454447
Income Tax Expense
0.0170.0210.0245.5510.8856.765677
Net Income
Net Income
(14.9)(17.49)(16.22)15.84(13.24)3.738827
Supplemental
EBIT
(11.97)(13.53)(12.03)25.75(4.727682)22.74
EBITDA
(11.92)(13.32)(11.83)25.94(4.554559)23.11
In millions of CHF, except % and values per 1 share